Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting
03 mai 2023 08h58 HE
|
Neuronetics
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
02 mai 2023 09h01 HE
|
Neuronetics
A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
01 mai 2023 08h46 HE
|
Neuronetics
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Access through United HealthCare
28 avr. 2023 16h11 HE
|
Neuronetics
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
13 avr. 2023 08h58 HE
|
Neuronetics
MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities
06 avr. 2023 16h16 HE
|
Neuronetics
MALVERN, Pa., April 06, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
16 mars 2023 08h56 HE
|
Neuronetics
MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
02 mars 2023 16h02 HE
|
Neuronetics
MALVERN, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform
23 févr. 2023 08h56 HE
|
Neuronetics
MALVERN, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Sponsors the 5th International Brain Stimulation Conference
21 févr. 2023 08h53 HE
|
Neuronetics
MALVERN, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...